Everolimus (everolimus tablets) NDC 51991-379

NDC codes

FDA NDC Directory

Product NDC (as listed)51991-379Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51991-0379Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51991-379-06	51991037906	60 TABLET in 1 BOTTLE (51991-379-06)Marketed from Mar 13, 2023
51991-379-60	51991037960	60 BLISTER PACK in 1 CARTON (51991-379-60) / 10 TABLET in 1 BLISTER PACK (51991-379-99)Marketed from May 21, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Everolimus
Generic name (nonproprietary): everolimus tablets
Active ingredients: Everolimus — .25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Breckenridge Pharmaceutical, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205432
Marketing start: May 21, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Decreased Immunologic Activity (Physiologic effect)Protein Kinase Inhibitors (Mechanism)mTOR Inhibitors (Mechanism)
Identifiers: Product ID 51991-379_42ae2051-c48f-49a0-a825-9f116623b2baSPL ID 42ae2051-c48f-49a0-a825-9f116623b2baSPL set ID c7bb6ba1-9a7f-43f5-b058-ef26d4b59221RxCUI 977427, 977434, 977438, 2056895UNII 9HW64Q8G6GUPC 0351991985068, 0351991379997, 0351991985990, 0351991380061, 0351991379065, 0351991380993, 0351991381990, 0351991381068
Pharmacologic class: Kinase Inhibitor; mTOR Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451991037906 followed by a unit qualifier and the quantity

Package 51991-0379-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 205432

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205432
Product	Strength	Form · route	Labeler	Product NDC
Everolimuseverolimus tablets	Everolimus 1 mg/1	TabletOral	Breckenridge Pharmaceutical, Inc.	51991-985
Everolimus	Everolimus .5 mg/1	TabletOral	Natco Pharma Limited	63850-0063
Everolimus	Everolimus .25 mg/1	TabletOral	Natco Pharma Limited	63850-0062
Everolimus	Everolimus .75 mg/1	TabletOral	Natco Pharma Limited	63850-0064
Everolimus	Everolimus 1 mg/1	TabletOral	Natco Pharma Limited	63850-0107
Everolimuseverolimus tablets	Everolimus .75 mg/1	TabletOral	Breckenridge Pharmaceutical, Inc.	51991-381
Everolimuseverolimus tablets	Everolimus .5 mg/1	TabletOral	Breckenridge Pharmaceutical, Inc.	51991-380